These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12216109)

  • 1. Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells.
    Lee HJ; Kim E; Jee B; Hahn JH; Han K; Jung KC; Park SH; Lee H
    Exp Mol Med; 2002 Jul; 34(3):177-83. PubMed ID: 12216109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
    Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
    J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
    Jee B; Jin K; Hahn JH; Song HG; Lee H
    Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
    Wang F; Nohara K; Olivera A; Thompson EW; Spiegel S
    Exp Cell Res; 1999 Feb; 247(1):17-28. PubMed ID: 10047444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.
    Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
    Oncogene; 2007 Oct; 26(46):6604-18. PubMed ID: 17471235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines.
    Golubovskaya VM; Gross S; Kaur AS; Wilson RI; Xu LH; Yang XH; Cance WG
    Mol Cancer Res; 2003 Aug; 1(10):755-64. PubMed ID: 12939401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
    Brunton VG; Ozanne BW; Paraskeva C; Frame MC
    Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
    Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
    Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1.
    Strell C; Lang K; Niggemann B; Zaenker KS; Entschladen F
    Exp Cell Res; 2010 Jan; 316(1):138-48. PubMed ID: 19747913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes.
    Liu R; Lioté F; Rose DM; Merz D; Terkeltaub R
    Arthritis Rheum; 2004 Jan; 50(1):247-58. PubMed ID: 14730623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation.
    Tang ZN; Zhang F; Tang P; Qi XW; Jiang J
    Oncol Rep; 2011 Nov; 26(5):1243-50. PubMed ID: 21725611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells.
    Kam AY; Chan AS; Wong YH
    J Pharmacol Exp Ther; 2004 Jul; 310(1):301-10. PubMed ID: 14996948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
    Slack JK; Adams RB; Rovin JD; Bissonette EA; Stoker CE; Parsons JT
    Oncogene; 2001 Mar; 20(10):1152-63. PubMed ID: 11313859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.